C-Path DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Default Key Product, Service and Excipients

C-Path And CENTOGENE MOU To Enhance Collaboration In Lysosomal Disease Research

20 Jun 2024

// GLOBENEWSWIRE

Jazz Pharma receive FDA approval for biliary tract cancer treatment

21 Nov 2024

// REUTERS

Trump likely to pick Johns Hopkins surgeon, for FDA, sources say

21 Nov 2024

// REUTERS

DATA COMPILATION
#PharmaFlow

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Website

BMWS24

Not Confirmed

Book a meeting

envelop Contact Supplier

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

About

Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies.